Treatment of focal dystonias with botulinum neurotoxin

Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L Comella

doi:10.1016/j.toxicon.2008.12.008

Treatment of focal dystonias with botulinum neurotoxin

Toxicon. 2009 Oct;54(5):628-33. doi: 10.1016/j.toxicon.2008.12.008. Epub 2008 Dec 13.

Authors

Mark Hallett¹, Reiner Benecke, Andrew Blitzer, Cynthia L Comella

Affiliation

¹ Human Motor Control Section, NINDS, NIH, Building 10, Room 7D37, 10 Center Dr MSC 1428, Bethesda, MD 20892-1428, USA. hallettm@ninds.nih.gov

Abstract

This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Botulinum Toxins / therapeutic use*
Dystonic Disorders / classification
Dystonic Disorders / drug therapy*
Humans
Neuromuscular Agents / therapeutic use*

Substances

Neuromuscular Agents
Botulinum Toxins

Grants and funding

ZIA NS003032-05/ImNIH/Intramural NIH HHS/United States